News Results

There are 915,752 News Results

May 9, 2024
HearUSA Helps Los Angeles Mother Stay Present for Every Moment with Her Children
This Mother's Day, Tamra Dale reflects on how addressing her hearing health has enhanced her connection with her children now and in the years to come.
May 13, 2024
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy
PALO ALTO, Calif., May 13, 2024 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of...
May 15, 2024
Movano Health Reports Q1 2024 Financial Results and Provides Business Update
Submits exemplary Sp02 clinical trial results as part of FDA 510(k) clearance process Plans launch of Evie Med and focuses on B2B opportunities Plans arterial blood pressure study for June...
May 22, 2024
Nikon Announces Judging Panel for the 50th Annual Nikon Small World Competition
Six judges will choose this year's winning microscopy images and videos for the 50th anniversary of the competition.
May 28, 2024
Global Micro- and Nanocellulose Market Report 2024-2035, with Profiles of 200+ Companies Including Anomera, Cellucomp, Celluforce, Melodea, Nippon Paper, Norkse Skog, Sappi, Stora Enso, Suzano and UPM - ResearchAndMarkets.com
The "Global Market for Micro- and Nanocellulose 2024-2035" report has been added to
May 28, 2024
Neurocrine Biosciences to Present New Phase 3 CAHtalyst(TM) Data in Adult and Pediatric Patients with CAH and Study Data for Modified-Release Hydrocortisone in Primary Adrenal Insufficiency and CAH at ENDO 2024
-- New CAHtalyst(TM) Pediatric and CAHtalyst(TM) Adult Phase 3 Clinical Study Data in Congenital Adrenal Hyperplasia -- CAHtalog(TM) Registry Data Highlighting Impact of Supraphysiologic Glucocorticoid Dosing -- Phase 2 (CHAMPAIN)...
Jun 13, 2024
Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.
JERUSALEM, June 13, 2024 /PRNewswire/ --
Jun 22, 2024
NeuroBo Pharmaceuticals' DA-1726 Demonstrated Superiority in Weight Loss, Retention of Lean Body Mass, and Lipid-Lowering Effects Compared to Survodutide, in Pre-Clinical Models
DA-1726 Also Exhibited Superior Glucose Lowering Compared to Survodutide
Jun 22, 2024
Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association's 84th Scientific Sessions
BEIJING and BRIDGEWATER, N.J., June 22, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087) announced the results of the Phase 1b/2a clinical study of...
Jun 24, 2024
Engine Capital Sends Letter to C&C Group’s Board of Directors Calling for a Review of Strategic Alternatives
Engine Capital, LP, which owns just under 5% of C&C Group Plc’s (LSE: CCR) outstanding common shares, today sent the below letter to C&C Group Plc’s Board of Directors. ***...
91576

Pages

1

Stories of the day

Sep 9, 2025
Elbit Systems Launches Frontier: Next-Generation AI-Based System to Tackle...
Sep 9, 2025
Maxar Partners with Anduril to Power U.S Army’s Mixed-Reality Combat System
Sep 10, 2025
HENSOLDT offers Spexer radar as naval solution
Sep 10, 2025
QinetiQ’s Uncrewed Aerial Target milestone showcases sovereign capability